NDC 50090-5960-01 - Losartan Potassium and Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-5960
- Requested NDC
- 50090-5960-01
- Package NDCs from labels
- 50090-5960-0, 50090-5960-2, 50090-5960-1, 50090-5960-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2024-05-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Losartan Potassium and Hydrochlorothiazide - A-S Medication Solutions | A-S Medication Solutions | 2024-05-06 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-5960-0 | Losartan Potassium and Hydrochlorothiazide | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 7 | |
| 50090-5960-1 | Losartan Potassium and Hydrochlorothiazide | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 7 | |
| 50090-5960-2 | Losartan Potassium and Hydrochlorothiazide | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-5960 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [A-S MEDICATION SOLUTIONS] | 7 | Current NDC, Legacy NDC, 3 package rows | 20240511_1bb08103-04ee-47a6-a9ad-290e169feb51.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-5960-0 | EA - Each | 50090-5960 | 236055f1-416d-4476-9b0a-73e1e0487b4e | 1 | 2022-07-06 |
| 50090-5960-1 | EA - Each | 50090-5960 | 7d68ca49-dafa-447b-a05c-8d0bc0a3e141 | 1 | 2022-07-06 |
| 50090-5960-2 | EA - Each | 50090-5960 | 4e10ae2d-dd32-475b-9ed6-a7938f3dac25 | 1 | 2023-04-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dolce and Gabbana Everlast Foundation SPF 20 12N Light Medium | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 26062cd7-3817-46c7-b65f-92cd57eca5dd | 2025-08-05 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 13C Light Medium | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 448a24a3-91ef-4530-828c-e77d8aae7f0b | 2025-08-05 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 02C Light | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 09f9e59b-6f71-4d42-9b5d-275f756d985b | 2025-08-04 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 03W Light | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 3b1e4480-8409-425e-b98d-eb4dcf2471e8 | 2025-08-04 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 06W Light | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 3090422e-fc18-45b8-88f2-6a9b282a7205 | 2025-08-04 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 05N Light | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | f93aa5d2-90ab-4e11-874e-2ede4b25c4b6 | 2025-08-04 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 04C Light | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | f055cd51-7b1d-43df-8990-8f60ba1eb91c | 2025-08-04 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 07N Light | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | d4c76bc5-205b-45fd-8a02-4f4b17458503 | 2025-08-04 | Warnings | 15FIX9V2JP |
| Olmesartan medoxomil Amlodipine and Hydrochlorothiazide | OLMESARTAN MEDOXOMIL AMLODIPINE AND HYDROCHLOROTHIAZIDE | Macleods Pharmaceuticals Limited | 52c013e1-8c31-4bed-9241-e7845873ebe8 | 2025-08-04 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Preferred Pharmaceuticals Inc. | 46cf633d-70a5-4d3b-b349-ad74c23ddace | 2025-08-04 | Boxed warning, Warnings, Adverse reactions | 979468 3ST302B24A 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Preferred Pharmaceuticals Inc. | 24ee299f-4466-45d4-9013-17791e1998bb | 2025-08-04 | Boxed warning, Warnings, Adverse reactions | 979471 3ST302B24A 0J48LPH2TH |
| Losartan Potassium | LOSARTAN POTASSIUM | Preferred Pharmaceuticals Inc. | 68ed9727-987e-4bb6-98b4-b98150bb6404 | 2025-08-01 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| VALSARTAN AND HYDROCHLOROTHIAZIDE | VALSARTAN AND HYDROCHLOROTHIAZIDE | Solco Healthcare US, LLC | f8b0a8ab-4549-4553-a127-bf2c0291a4b1 | 2025-07-31 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals, Inc. | 3b3c92b1-bec3-2768-e063-6394a90a9af8 | 2025-07-31 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Neutrogena Mineral Invisible Daily Defense Face Sunscreen Broad Spectrum SPF 30 | TITANIUM DIOXIDE, ZINC OXIDE | Kenvue Brands LLC | 003123d2-9675-fdd2-e063-6294a90a0130 | 2025-07-28 | Warnings | 15FIX9V2JP |
| Neutrogena Mineral Ultra Sheer Face SPF 70 | TITANIUM DIOXIDE, ZINC OXIDE | Kenvue Brands LLC | 20e0badf-fe25-1d27-e063-6294a90a7cfe | 2025-07-28 | Warnings | 15FIX9V2JP |
| Losartan potassium | LOSARTAN POTASSIUM | Macleods Pharmaceuticals Limited | 85d69d02-c5ef-467e-94aa-903100218795 | 2025-07-28 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Dolce and Gabbana Everlast Foundation SPF 20 01N Light | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 2ccf4e45-4cec-417d-9f4c-28f376025f1d | 2025-07-25 | Warnings | 15FIX9V2JP |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | Solco Healthcare LLC | 96922ddc-e87f-4670-b22e-0ffd0d8f66e1 | 2025-07-25 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Sunscreen | TITANIUM DIOXIDE 6.8% | Baxter of California, LLC | 146030bc-2bf4-25ea-e063-6294a90a4613 | 2025-07-24 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.